TIKUN OLAM-CANNBIT PHARMACEUTICALS LTD Inactive Instrument
Tikun Olam-Cannbit Pharmaceuticals Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
TKUN
IL0010843675
Pharmaceuticals
| Sales 2022 | 49.3 184.78 67.36 | Sales 2023 | 44.23 165.78 60.44 | Capitalization | 25.49M 95.54M 34.83M |
|---|---|---|---|---|---|
| Net income 2022 | -48M -180M -65.59M | Net income 2023 | -88M -330M -120M | EV / Sales 2022 | 1,234,605 x |
| Net Debt 2022 | 17.5M 65.6M 23.92M | Net Debt 2023 | 13.42M 50.3M 18.34M | EV / Sales 2023 | 879,698 x |
| P/E ratio 2022 |
-0.97
x | P/E ratio 2023 |
-0.22
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 66.73% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Erez Navon
BRD | Director/Board Member | 50 | - |
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Yaron Razon
BRD | Director/Board Member | - | - |
Tikun Olam Cannbit Pharmaceuticals Ltd, formerly Cannbit Pharmaceuticals Ltd, is an Israel-based company that produces medical cannabis. The Company engages in growing and cultivating medical cannabis products.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +23.96% | 3.66B | |
| +114.31% | 2B | |
| +90.48% | 61.69M |
